0000950170-23-031637.txt : 20230705
0000950170-23-031637.hdr.sgml : 20230705
20230705161945
ACCESSION NUMBER: 0000950170-23-031637
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230701
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Alleva Lawrence M
CENTRAL INDEX KEY: 0001553053
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39114
FILM NUMBER: 231069296
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3300
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Galera Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563577
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 461454898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
BUSINESS PHONE: 610-725-1500
MAIL ADDRESS:
STREET 1: 45 LIBERTY BLVD.
STREET 2: SUITE 230
CITY: MALVERN
STATE: PA
ZIP: 19355
4
1
ownership.xml
4
X0407
4
2023-07-01
0001563577
Galera Therapeutics, Inc.
GRTX
0001553053
Alleva Lawrence M
C/O GALERA THERAPEUTICS, INC.,
45 LIBERTY BLVD #230
MALVERN
PA
19355
true
false
false
false
false
Stock Option (Right to Buy)
3.12
2023-07-01
4
A
false
22762
0
A
2033-06-30
Common Stock
22762
22762
D
This option was awarded pursuant to the "elective option" provisions of the Issuer's non-employee director compensation program for the Reporting Person's service on the Issuer's Board and certain of its committees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date.
/s/ Christopher Degnan, Attorney-in-Fact for Lawrence M. Alleva
2023-07-05